Skip to main content

Table 1 General profile of the MDR-TB patients notified between 2011 and 2013

From: Treatment outcome of multidrug-resistant tuberculosis in Japan – the first cross-sectional study of Japan tuberculosis surveillance data

Notification year 2011 2012 2013 2011–2013
  n % n % n % n %
Total 59 100.0 64 100.0 49 100.0 172 100.0
Sex
 Male 36 61.0 47 73.4 35 71.4 118 68.6
 Female 23 39.0 17 26.6 14 28.6 54 31.4
Country of birth
 Japan-born 46 78.0 45 70.3 31 63.3 122 70.9
 Foreign-born 12 20.3 15 23.4 16 32.7 43 25.0
 Unknown 1 1.7 4 6.3 2 4.1 7 4.1
Age groups
 0–14 0 0.0 0 0.0 0 0.0 0 0.0
 15–64 32 54.2 33 51.6 30 61.2 95 55.2
 65+ 27 45.8 31 48.4 19 38.8 77 44.8
Treatment history
 New 37 62.7 42 65.6 33 67.3 112 65.1
 Retreatment 22 37.3 22 34.4 16 32.7 60 34.9
  1. MDR-TB Multidrug-resistant TB, New: patient receiving TB treatment for the first time, Retreatment: patient who has previously received anti-TB drugs for more than 1 month